Overview

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.
Phase:
N/A
Details
Lead Sponsor:
Solvay Pharmaceuticals
Treatments:
Eprosartan